Literature DB >> 27377630

Cognitive deficits in single App knock-in mouse models.

Akira Masuda1, Yuki Kobayashi2, Naomi Kogo3, Takashi Saito4, Takaomi C Saido5, Shigeyoshi Itohara6.   

Abstract

Transgenic mouse models of Alzheimer's disease (AD) with nonphysiologic overexpression of amyloid precursor protein (APP) exhibit various unnatural symptoms/dysfunctions. To overcome this issue, mice with single humanized App knock-in (KI) carrying Swedish (NL), Beyreuther/Iberian (F), and Arctic (G) mutations in different combinations were recently developed. The validity of these mouse models of AD from a behavioral viewpoint, however, has not been extensively evaluated. Thus, using an automated behavior monitoring system, we analyzed various behavioral domains, including executive function, and learning and memory. The App-KI mice carrying NL-G-F mutations showed clear deficits in spatial memory and flexible learning, enhanced compulsive behavior, and reduced attention performance. Mice carrying NL-F mutations exhibited modest abnormalities. The NL-G-F mice had a greater and more rapid accumulation of Aβ deposits and glial responses. These findings reveal that single pathologic App-KI is sufficient to produce deficits in broad cognitive domains and that App-KI mouse lines with different levels of pathophysiology are useful models of AD.
Copyright © 2016 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer’s disease; Amyloid precursor protein; Cognition; IntelliCage; Model mouse; Sex

Mesh:

Substances:

Year:  2016        PMID: 27377630     DOI: 10.1016/j.nlm.2016.07.001

Source DB:  PubMed          Journal:  Neurobiol Learn Mem        ISSN: 1074-7427            Impact factor:   2.877


  65 in total

1.  Reduction of advanced tau-mediated memory deficits by the MAP kinase p38γ.

Authors:  Arne Ittner; Lars M Ittner; Prita Riana Asih; Amanda R P Tan; Emmanuel Prikas; Josefine Bertz; Kristie Stefanoska; Yijun Lin; Alexander M Volkerling; Yazi D Ke; Fabien Delerue
Journal:  Acta Neuropathol       Date:  2020-07-29       Impact factor: 17.088

2.  Deuterated polyunsaturated fatty acids reduce brain lipid peroxidation and hippocampal amyloid β-peptide levels, without discernable behavioral effects in an APP/PS1 mutant transgenic mouse model of Alzheimer's disease.

Authors:  Sophia M Raefsky; Ran Furman; Ginger Milne; Erik Pollock; Paul Axelsen; Mark P Mattson; Mikhail S Shchepinov
Journal:  Neurobiol Aging       Date:  2018-03-05       Impact factor: 4.673

3.  Temporal progression of Alzheimer's disease in brains and intestines of transgenic mice.

Authors:  Gunjan D Manocha; Angela M Floden; Nicole M Miller; Abbie J Smith; Kumi Nagamoto-Combs; Takashi Saito; Takaomi C Saido; Colin K Combs
Journal:  Neurobiol Aging       Date:  2019-06-13       Impact factor: 4.673

4.  Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage.

Authors:  Akira Masuda; Yuki Kobayashi; Shigeyoshi Itohara
Journal:  J Vis Exp       Date:  2018-08-04       Impact factor: 1.355

5.  Longitudinal PET Monitoring of Amyloidosis and Microglial Activation in a Second-Generation Amyloid-β Mouse Model.

Authors:  Christian Sacher; Tanja Blume; Leonie Beyer; Finn Peters; Florian Eckenweber; Carmelo Sgobio; Maximilian Deussing; Nathalie L Albert; Marcus Unterrainer; Simon Lindner; Franz-Josef Gildehaus; Barbara von Ungern-Sternberg; Irena Brzak; Ulf Neumann; Takashi Saito; Takaomi C Saido; Peter Bartenstein; Axel Rominger; Jochen Herms; Matthias Brendel
Journal:  J Nucl Med       Date:  2019-07-13       Impact factor: 10.057

6.  Effect of Scopolamine on Mice Motor Activity, Lick Behavior and Reversal Learning in the IntelliCage.

Authors:  Péter Pelsőczi; György Lévay
Journal:  Neurochem Res       Date:  2017-10-11       Impact factor: 3.996

7.  Istradefylline reduces memory deficits in aging mice with amyloid pathology.

Authors:  Anna G Orr; Iris Lo; Heike Schumacher; Kaitlyn Ho; Michael Gill; Weikun Guo; Daniel H Kim; Anthony Knox; Takashi Saito; Takaomi C Saido; Jeffrey Simms; Carlee Toddes; Xin Wang; Gui-Qiu Yu; Lennart Mucke
Journal:  Neurobiol Dis       Date:  2017-10-31       Impact factor: 5.996

Review 8.  Alzheimer's disease pathology in APOE transgenic mouse models: The Who, What, When, Where, Why, and How.

Authors:  Cutler T Lewandowski; Juan Maldonado Weng; Mary Jo LaDu
Journal:  Neurobiol Dis       Date:  2020-02-20       Impact factor: 5.996

9.  A loss-of-function variant in SUV39H2 identified in autism-spectrum disorder causes altered H3K9 trimethylation and dysregulation of protocadherin β-cluster genes in the developing brain.

Authors:  Shabeesh Balan; Yoshimi Iwayama; Tetsuo Ohnishi; Mikiko Fukuda; Atsuko Shirai; Ayumi Yamada; Sara Weirich; Maren Kirstin Schuhmacher; Kalarickal Vijayan Dileep; Toshihiro Endo; Yasuko Hisano; Kaoru Kotoshiba; Tomoko Toyota; Takeshi Otowa; Hitoshi Kuwabara; Mamoru Tochigi; Akiko Watanabe; Hisako Ohba; Motoko Maekawa; Manabu Toyoshima; Tsukasa Sasaki; Kazuhiko Nakamura; Masatsugu Tsujii; Hideo Matsuzaki; Kam Y J Zhang; Albert Jeltsch; Yoichi Shinkai; Takeo Yoshikawa
Journal:  Mol Psychiatry       Date:  2021-07-15       Impact factor: 15.992

10.  Sex differences in the IntelliCage and the Morris water maze in the APP/PS1 mouse model of amyloidosis.

Authors:  Marc A Mifflin; Wendy Winslow; Likith Surendra; Savannah Tallino; Austin Vural; Ramon Velazquez
Journal:  Neurobiol Aging       Date:  2021-01-23       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.